Loading lessons…
Loading lessons…
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
Choose a learning path below or search the library. Progress saves in your browser.
Prefer timeline chaos? Peptide X Quiz · Literacy certify
Pick a track — progress rings update as you complete lessons.
13 lessons
9mNAD+ is essential to cells. That does not make every NAD+ treatment effective. A practical guide to IV claims, oral precursors and what human studies actually measured.
10mThe collagen powder in a grocery store and the vial labeled "research use only" share one word and almost nothing else. This guide explains what each one is, how each is regulated, what the human evidence shows for collagen on skin, joints and bone, and where the copper peptide GHK-Cu fits.
12mA goal-by-goal map of the peptides people ask about most, scored on human evidence and regulatory status. The only ones with strong evidence are approved drugs; most of the rest are animal data. No vendors, no dosing.
8m"Wolverine" is a nickname for BPC-157 plus TB-500. Here's what's in the blend, how the vial math works, how it compares with GLOW and KLOW, and how thin the human evidence still is.
10mThe latest sports medicine review is useful because it separates promising recovery biology from the human evidence gap and the antidoping risks.
9mThe new BPC-157 review is useful because it separates mechanism from marketing. The peptide looks biologically interesting, but the human evidence is still thin.
9mWeight regain after stopping GLP-1 treatment is common in trials. Understand the evidence, the numbers, and the questions that make a maintenance conversation useful.
7mAMA and FDA updates make one thing clear: peptide interest is moving faster than human evidence, dosing standards, and product-quality controls. Use this checklist before trusting a vial.
8mA new sports medicine review puts injury-recovery peptides in context. Some mechanisms are promising, but human evidence, safety data, and regulatory status still matter.
9mFood thoughts, hunger and weight are different outcomes. Learn what human studies show about GLP-1 treatment and what returning food noise can—and cannot—tell you.
10mEpitalon is a lab-made four-amino-acid peptide based on a pineal gland extract. It lengthens telomeres in cell studies, but human evidence is small and old. It is not FDA approved, and since October 2026 it is one of six peptides in an HHS compounding policy.
9mTwo products share the CJC-1295 name. Learn what the Drug Affinity Complex changes, what the 2006 human studies actually measured, and why the no-DAC version has far less published evidence.
9mRetatrutide is often marketed as muscle-sparing. The published scans tell a narrower story: mostly fat loss, some lean loss, and no head-to-head body-composition data against tirzepatide yet.
Also available at /blog for legacy links.